Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
October 3, 1999
Pathophysiologic basis of contrast enhancement in breast tumors
M V Knopp, E Weiss, H P Sinn, et al.
Radiology
|
November 1, 1996
Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging
H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Biology & Therapy
|
December 17, 2005
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging
M E Eichhorn, S Becker, S Strieth, et al.
Der Radiologe
|
April 8, 1998
[Angiogenesis of cervix carcinoma. Contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration]
H Hawighorst, P G Knapstein, M V Knopp, et al.
European Radiology
|
March 19, 2004
Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring?
F Kiessling, J Boese, C Corvinus, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 14, 1998
Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results
H Hawighorst, M V Knopp, J Debus, et al.
Magnetic Resonance in Medicine
|
March 3, 2012
Quantification of pulmonary microcirculation by dynamic contrast-enhanced magnetic resonance imaging: comparison of four regularization methods
M Salehi Ravesh, G Brix, F B Laun, et al.
Cancer Research
|
November 14, 1997
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Biology & Therapy
|
May 31, 2007
Cationic lipid complexed camptothecin (EndoTAG-2) improves antitumoral efficacy by tumor vascular targeting
M E Eichhorn, S Luedemann, S Strieth, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 22, 2004
[5 years of "concerted action dose reduction in CT" -- what has been achieved and what remains to be done?]
H D Nagel, J Blobel, G Brix, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Journal of Magnetic Resonance Imaging : JMRI
|
October 3, 1999
Pathophysiologic basis of contrast enhancement in breast tumors
M V Knopp, E Weiss, H P Sinn, et al.
Radiology
|
November 1, 1996
Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging
H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Biology & Therapy
|
December 17, 2005
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging
M E Eichhorn, S Becker, S Strieth, et al.
Der Radiologe
|
April 8, 1998
[Angiogenesis of cervix carcinoma. Contrast enhanced dynamic MRI, histologic quantification of capillary density and lymphatic system infiltration]
H Hawighorst, P G Knapstein, M V Knopp, et al.
European Radiology
|
March 19, 2004
Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring?
F Kiessling, J Boese, C Corvinus, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 14, 1998
Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results
H Hawighorst, M V Knopp, J Debus, et al.
Magnetic Resonance in Medicine
|
March 3, 2012
Quantification of pulmonary microcirculation by dynamic contrast-enhanced magnetic resonance imaging: comparison of four regularization methods
M Salehi Ravesh, G Brix, F B Laun, et al.
Cancer Research
|
November 14, 1997
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
H Hawighorst, P G Knapstein, W Weikel, et al.
Cancer Biology & Therapy
|
May 31, 2007
Cationic lipid complexed camptothecin (EndoTAG-2) improves antitumoral efficacy by tumor vascular targeting
M E Eichhorn, S Luedemann, S Strieth, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 22, 2004
[5 years of "concerted action dose reduction in CT" -- what has been achieved and what remains to be done?]
H D Nagel, J Blobel, G Brix, et al.
Page
of 16